NLS Pharma
NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.
NLS Pharma has raised €4.9M across 2 funding rounds from 1 investor, most recently a round in Apr 2025. Based in Stans, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Stans, Netherlandsnlspharma.com ↗
Total raised
€4.9M
€4,856,939
Funding rounds
2
Investors
1
distinct backers
Active since
2021-09
latest 2025-04
Funding by year
EUR raised per yearNLS Pharma — funding by year — interactive chart.
Data table
| NLS Pharma — funding by year | |
|---|---|
| 2021 | €2.1M |
| 2025 | €2.7M |
Signals
Medium confidenceRaise-next likelihood49
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-04-09 | Other | €2.7M | — | View deal → |
| 2021-09-28 | Other | €2.1M | YA | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData